--- title: Five Years After CAR-T for Relapsed Leukemia, He's Now the Fastest Runner in His Class url: "https://www.yyhmedical.com/en/stories/childhood-b-all-car-t-five-year-recovery" type: Article inLanguage: en-US disease: B-Cell Acute Lymphoblastic Leukemia treatment: CAR-T datePublished: 2026-08-21 --- # Five Years After CAR-T for Relapsed Leukemia, He's Now the Fastest Runner in His Class > Keke (pseudonym) was diagnosed with leukemia before the age of two. After relapse in the bone marrow and both testes, he received CAR-T Summary: Keke was diagnosed with B-cell acute lymphoblastic leukemia (B-ALL) before he turned two. After nearly three and a half years of treatment, he stopped therapy, only to develop a bone marrow relapse with leukemic involvement of both testes a little over six months later. After the relapse, his family began actively exploring new treatment options. Following medical evaluation, Keke received sequential CD19 and CD22 CAR-T cell therapy, followed by consolidation treatment. He also faced infectious complications after CAR-T, including Pneumocystis jirovecii pneumonia (PJP), but gradually recovered with appropriate treatment and long-term follow-up. Now, five years after CAR-T therapy, Keke is back at school. He loves PE, running, and badminton, and has begun imagining what he wants to be when he grows up. ## **Leukemia Relapsed Just Over Six Months After Treatment Ended** Keke was diagnosed with B-cell acute lymphoblastic leukemia before he was two years old. For nearly three and a half years, he received chemotherapy according to his treatment plan. Overall, the course went relatively smoothly. After treatment ended, Keke was eating well, running around, and full of energy. To anyone looking at him, he seemed just like any other child. The family thought the long treatment journey was finally behind them. But a little over six months later, before Keke's mother returned to work, she decided to take him for a comprehensive follow-up. The results brought news no one had expected: the leukemia had relapsed. The relapse involved not only the bone marrow, but also leukemic infiltration of both testes. "When he was first diagnosed, we knew childhood leukemia could often be treated successfully. We were scared, of course, but we still felt that if we followed the treatment plan, things would work out. We never imagined the leukemia would come back only a little over six months after he stopped treatment." This time, the situation was more complex than at initial diagnosis. ## **Why Did the Family Start Looking Into CAR-T After Relapse?** During Keke's initial treatment, his mother mostly followed the medical team's plan step by step and did not actively research many other treatment options. Once the leukemia relapsed, she gradually realized that the decisions ahead would be very different from those they had faced during first-line treatment. She began looking for information on her own, speaking with other parents, and learning more about treatment options that might be considered for children with relapsed leukemia. "At the time, we had very limited access to information. We didn't know which children had been through relapse, or even who we should ask. Eventually, we found two families with similar experiences. Both had gone to Beijing, and that was when we started looking there too." Through conversations with other families, consultations with different doctors, and formal medical evaluation, the family gradually learned about CAR-T cell therapy. Keke's mother asked very practical questions: "How many children have you treated? Have you seen cases similar to ours? What were the outcomes?" Other families' experiences helped broaden what they knew, but she also came to understand an important point: every child's disease biology, site of relapse, previous treatment, and overall condition are different. Another patient's treatment journey can be useful for learning, but it cannot simply be copied. After gathering more information and completing further evaluation, the family decided to seek treatment from Dr. Jing PAN's team. ## **With Relapse in Both the Bone Marrow and Testes, Where Did CAR-T Fit Into the Treatment Plan?** After arriving in Beijing, the medical team carried out a comprehensive assessment, taking into account Keke's bone marrow relapse, bilateral testicular leukemic involvement, and previous treatment history. The team first used treatment to bring the disease under control. Once remission was achieved, Keke moved on to CAR-T therapy. He subsequently received CD19 CAR-T followed by CD22 CAR-T, and then completed additional consolidation treatment. After CAR-T cell infusion, Keke developed lower blood counts and a mild fever. Before treatment began, however, the doctors had already explained the reactions that might occur, which symptoms the family should watch for, and what would happen if a problem arose. So when these issues did appear, the family was still anxious, but no longer felt completely unprepared. Every day, Keke's mother recorded his temperature, energy level, and any physical changes. She followed the team's guidance on diet, medications, and daily care, and reported anything unusual promptly. She later reflected: "Parents don't have to force themselves to understand every piece of medical knowledge. What really matters is knowing what stage of treatment your child is in, what the doctors want you to watch for, and which changes need to be reported right away. Doing those things well is already very important." ## **Why Does Infection Prevention Still Matter After CAR-T?** About five months after his first CAR-T infusion, Keke suddenly developed a high fever. He had seemed completely well that morning, but by the afternoon he was running a high fever, without obvious respiratory symptoms such as cough or a runny nose. For the first two days, the cause was unclear. Considering Keke's stage of treatment and medical history, Dr. Jing PAN's team carried out further evaluation for infection. He was ultimately diagnosed with Pneumocystis jirovecii pneumonia (PJP). The infection kept Keke in the hospital for 23 days. Looking back, his mother feels the family may have relaxed their precautions a little too soon. "He looked no different from a healthy child, so we thought he had probably recovered quite well. We even took him to the park to play in the sand." The experience made the family understand more clearly that looking well and feeling energetic after CAR-T does not necessarily mean the immune system has fully recovered. During the recovery period recommended by the medical team, infection precautions, food hygiene, and a clean environment may still be important. If a child develops an unexpected fever or other concerning symptoms, the family should contact the treating team or seek medical care promptly. When normal activities can gradually resume should be decided according to follow-up results and the treating physician's assessment. ## **Five Years After CAR-T, He's Back on the Playground** After treatment ended, Keke's mother did not rush to send him straight back to school. Instead, she let him rest at home for another year. "I wanted him to recover as fully as possible first. One more year didn't matter." When Keke first returned to school, he still wore a mask. At first, his mother was also hesitant to let him join PE classes, although Keke himself loved being active. As his health became more stable, he gradually returned to normal physical activity. His mother also spoke with his teacher and said, "Just treat him like any other child. He doesn't need to be singled out." Now, five years after CAR-T therapy, PE is Keke's favorite class, and he also loves badminton. What makes his mother especially happy is that the little boy who once spent so much of his childhood in treatment is now one of the fastest runners in his class. When asked what he wants to be when he grows up, he answers seriously, "A soldier." He says he was impressed by how strong and proud the soldiers looked when he watched a military parade on television. Chemotherapy, follow-up visits, infections, and treatment once dominated the family's conversations. Today, they talk much more about school, PE, badminton, and what Keke might want to do in the future. It is the ordinary family life they once hoped so deeply to have again. ## **Five Lessons Keke's Mother Would Like to Share with Other Families** ## ## **Q: After a child's leukemia relapses, how can parents look for reliable information about new treatment options?** Relapsed disease may be very different from newly diagnosed leukemia, and treatment decisions can become more complex. Keke's mother suggests staying in close communication with the treating physician while also learning about the disease, experienced medical teams, and newer treatment developments, so that families are not left feeling powerless simply because they lack information. ## ## **Q: Can another family's treatment experience be used as a direct guide for your own child?** Other families' experiences can help parents discover treatment options they may not have known about, but they should not be treated as a ready-made plan for another child. Children can differ in disease subtype, site of relapse, target antigen expression, previous treatment, and overall health. The treatment plan still needs to be individualized by an experienced medical team. ## ## **Q: If leukemia relapses outside the bone marrow, such as in the testes, does that automatically mean CAR-T is needed?** No. Not every child with relapsed leukemia needs CAR-T therapy. For children with relapse involving both the bone marrow and an extramedullary site such as the testes, the medical team needs to consider the location of relapse, disease burden, previous treatment, target antigen expression, and other clinical factors. CAR-T became an important part of Keke's treatment, but whether CAR-T is appropriate for a particular child should be decided individually by a team with relevant experience. ## ## **Q: If a child looks back to normal after CAR-T, do infection precautions still need to continue?** Yes, precautions may still be needed depending on the child's immune recovery. Keke developed Pneumocystis jirovecii pneumonia about five months after CAR-T. A child may look and feel much better before the immune system has fully recovered. During the period advised by the medical team, families may still need to pay attention to masking, environmental hygiene, food safety, and unexpected fever or other signs of infection. ## ## **Q: Do parents need to understand every medical detail about CAR-T?** No. Parents do not need to put that kind of pressure on themselves. More important than mastering every technical detail is understanding what stage of treatment the child is in, what symptoms need to be watched, when the medical team should be contacted immediately, and how to maintain clear communication with the child's doctors. ## **From the Hospital Ward to the Playground: A Child's Life Is About More Than Treatment** From being diagnosed with B-cell acute lymphoblastic leukemia before the age of two, to relapsing after treatment, receiving CAR-T therapy, facing a serious infection, and going through a long recovery, Keke and his family have traveled a very long road. Today, treatment is no longer the center of this child's life. He is back in the classroom and out on the playground, joining PE with his classmates, playing badminton, and seriously imagining what he might want to become when he grows up. For children and parents who are still in treatment, there may still be procedures, tests, and long periods of waiting ahead. But illness is only one part of a child's story. It does not mean they have lost the chance to have a future. They can still return to school, make new friends, discover new interests, and gradually build a life that belongs to them. > This content is published with the authorization of the patient and their family, intended solely to share real experiences and health knowledge. It does not constitute a recommendation of any treatment plan or medical diagnostic advice. For specific treatment, please follow the guidance of a professional physician. --- Original (HTML):https://www.yyhmedical.com/en/stories/childhood-b-all-car-t-five-year-recovery This is a clean Markdown mirror for large language models; the original page is authoritative.